Gridsum Announces Pricing of Initial Public Offering
Sep 23, 2016 12:00 pm UTC| Business
BEIJING, Sept. 23, 2016 -- Gridsum Holding Inc. (“Gridsum” or the “Company”) (NASDAQ:GSUM), a leading provider of sophisticated data analysis software in China, today announced that its initial public offering of...
Apricus Biosciences Announces $4.6 Million Registered Direct Offering
Sep 23, 2016 12:00 pm UTC| Business
SAN DIEGO, Sept. 23, 2016 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has entered into a definitive...
Catalyst Biosciences To Present at the Ladenburg Thalmann 2016 Healthcare Conference
Sep 23, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2016 -- Catalyst Biosciences, Inc. (Nasdaq:CBIO), a clinical-stage biotechnology company focused on creating and developing novel protease therapeutics to treat serious medical...
T-Mobile US, Inc. to Present at the Deutsche Bank 24th Annual Leveraged Finance Conference
Sep 23, 2016 12:00 pm UTC| Business
BELLEVUE, Wash., Sept. 23, 2016 -- J. Braxton Carter, Executive Vice President Chief Financial Officer of T-Mobile US, Inc. (NASDAQ:TMUS) will present at 8:40 a.m. Mountain Standard Time (11:40 a.m. Eastern Daylight...
Checkpoint Therapeutics to Present at the Ladenburg Thalmann 2nd Annual Healthcare Conference
Sep 23, 2016 12:00 pm UTC| Business
NEW YORK, Sept. 23, 2016 -- Checkpoint Therapeutics, Inc. (“Checkpoint”), a Fortress Biotech (NASDAQ:FBIO) company, announced today that James F. Oliviero, III, President and CEO of Checkpoint, will present at the...
Momenta Pharmaceuticals Appoints Corey N. Fishman to Board of Directors
Sep 23, 2016 12:00 pm UTC| Business
CAMBRIDGE, Mass., Sept. 23, 2016 -- Momenta Pharmaceuticals,Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the appointment of Corey N....
Stemline Therapeutics to Present at the Ladenburg Thalmann 2016 Healthcare Conference
Sep 23, 2016 11:32 am UTC| Business
NEW YORK, Sept. 23, 2016 -- Stemline Therapeutics, Inc. (Nasdaq:STML) announced today that Ivan Bergstein, M.D., Stemline’s CEO, will present at the Ladenburg Thalmann 2016 Healthcare Conference on Tuesday, September...
India–EU FTA Nears Finish Line Ahead of New Delhi Summit